Cargando…
Type I and type III collagen metabolites in adult osteosarcoma patients.
Three biochemical markers of collagen metabolism were measured in 39 osteosarcoma patients. The pretreatment values did not predict outcome, and the markers showed no consistent change upon development of metastases. Both the age of the patients and the multimodality therapy affected the collagen me...
Autores principales: | Wiklund, T., Blomqvist, C., Risteli, L., Risteli, J., Karaharju, E., Elomaa, I. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074279/ https://www.ncbi.nlm.nih.gov/pubmed/8554970 |
Ejemplares similares
-
Type III collagen metabolism in soft tissue sarcomas.
por: Wiklund, T. A., et al.
Publicado: (1992) -
Markers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinoma.
por: Blomqvist, C., et al.
Publicado: (1996) -
Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma.
por: Elomaa, I., et al.
Publicado: (1992) -
Aminoterminal propeptide of type I procollagen (PINP) correlates to bone loss and predicts the efficacy of antiresorptive therapy in pre- and post-menopausal non-metastatic breast cancer patients.
por: Saarto, T., et al.
Publicado: (1998) -
Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancer.
por: Kylmälä, T., et al.
Publicado: (1995)